LPP Plus Profile

Approximately 50 percent of people suffering from heart attacks have shown “normal” cholesterol numbers (NHLBI – The National Heart, Lung, and Blood Institute).

SpectraCell’s LPP™ Plus Profile is the most advanced lipoprotein test currently available. Unlike traditional cholesterol tests, SpectraCell’s LPP™ directly measures both the size and number of several classes of lipoprotein particles, including critical risk factors as cited by the National Cholesterol Education Program, giving an accurate assessment of cardiovascular risk.

Many people understand that not all cholesterol is the same. There is the “good” HDL (High Density Lipoprotein) cholesterol and the “bad” LDL (Low Density Lipoprotein) cholesterol. However, different types of HDL and LDL exist and some are much more dangerous than others. The LPP™ test determines the specific number of particles in each lipoprotein subclass (HDL and LDL) for a much more accurate assessment of risk. For example, the LPP™ test measures RLP (remnant lipoprotein) and Lp(a), both very atherogenic, but with very different effective treatment options. A standard cholesterol test does not give this information, putting the clinician at a disadvantage when deciding the most effective clinical treatment for their patient.

Moreover, since it is the actual lipoproteins (not the cholesterol inside them) that contribute to cardiovascular disease, the LPP™ test is more advanced than standard cholesterol testing or other advanced cholesterol testing technologies. The LPP™ test measures the lipoprotein particles directly, giving a precise evaluation of their size and density. Armed with this information, we are empowered to make the best possible decisions regarding your care when it comes to reducing cardiovascular risk.

The LPP Plus Profile provides an analysis of your fasting lipid profile, fasting insulin, C-reactive protein and lipoprotein sub fractions. In addition, this advanced profile also includes analyses of you lipoprotein particle numbers, homocysteine and Lipoprotein (a) levels, which can be used to provide valuable insights into which therapeutic approaches may be most effective to correct any underlying metabolic or inflammatory imbalances which may be at the heart of insulin resistance, blood sugar dysregulation and/or cardiovascular disease risk.

A blood draw is required to complete this test; if you do not have a blood draw site near you, click here to locate one in your area.

A copy of the test results will be sent to you along with detailed recommendations to correct any imbalances.